Quality of life and retention in care among people living with HIV initiated on ART in the era of "Universal Test and Treat" policy at a large HIV Clinic in South Western Uganda.

<h4>Background</h4>Anti-retroviral therapy (ART) improves the quality of life (QoL) among people living with human immunodeficiency virus (PLWH). Most studies documenting the gains in QoL have been conducted among persons starting treatment at advanced HIV disease. In the era of Universa...

Full description

Saved in:
Bibliographic Details
Main Authors: Faith Tumuhairwe, Jonathan Izudi, Abel Munina, Anthanasio Bashaija, Francis Bajunirwe
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2025-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0324024
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849715777944420352
author Faith Tumuhairwe
Jonathan Izudi
Abel Munina
Anthanasio Bashaija
Francis Bajunirwe
author_facet Faith Tumuhairwe
Jonathan Izudi
Abel Munina
Anthanasio Bashaija
Francis Bajunirwe
author_sort Faith Tumuhairwe
collection DOAJ
description <h4>Background</h4>Anti-retroviral therapy (ART) improves the quality of life (QoL) among people living with human immunodeficiency virus (PLWH). Most studies documenting the gains in QoL have been conducted among persons starting treatment at advanced HIV disease. In the era of Universal Test and Treat (UTT) policy, most PLWH start ART early with high CD4 counts. Therefore, we investigated the association between baseline CD4 count with QoL and retention among PLWH during UTT in southwestern Uganda.<h4>Methods</h4>Between June 11, 2019, and June 10, 2020, we reviewed medical records for PLWH initiated on ART between April 2017 and September 2018 and interviewed them to collect QoL data. The primary exposure was CD4 count at ART initiation categorized as <500 cells/µl (low) versus ≥500 cells/µl (high). Physical and mental health-related QoL were the primary outcomes. Retention was the secondary outcome. Binary logistic regression was used to assess the association between the exposure and the primary outcome, while the Cox Proportional Hazard regression model was used for the secondary outcome.<h4>Results</h4>Of 300 participants, 59.7% initiated ART at a low baseline CD4 count. ART initiation at a higher baseline CD4 count, compared to a lower baseline CD4 count, was associated with a lower mental health-related QoL (adjusted odds ratio [aOR] 0.56, 95% confidence interval [CI] 0.32-0.97) but similar physical health-related QoL (aOR 0.54, 95% CI 0.10-2.78) and retention (adjusted hazard ratio [aHR] 0.30, 95% CI 0.08-1.14).<h4>Conclusion</h4>In this cohort of PLWH on ART, those who initiated the treatment at a higher baseline CD4 were less likely to have good mental health-related QoL functioning compared to those initiating at lower CD4 counts. However, the two groups were comparable in physical health-related QoL and retention in care. PLWH initiating ART at a higher baseline CD4 may require mental health-related support as part of treatment.
format Article
id doaj-art-1f34b10ba16f4aa58c76f7ff881e1e97
institution DOAJ
issn 1932-6203
language English
publishDate 2025-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj-art-1f34b10ba16f4aa58c76f7ff881e1e972025-08-20T03:13:13ZengPublic Library of Science (PLoS)PLoS ONE1932-62032025-01-01205e032402410.1371/journal.pone.0324024Quality of life and retention in care among people living with HIV initiated on ART in the era of "Universal Test and Treat" policy at a large HIV Clinic in South Western Uganda.Faith TumuhairweJonathan IzudiAbel MuninaAnthanasio BashaijaFrancis Bajunirwe<h4>Background</h4>Anti-retroviral therapy (ART) improves the quality of life (QoL) among people living with human immunodeficiency virus (PLWH). Most studies documenting the gains in QoL have been conducted among persons starting treatment at advanced HIV disease. In the era of Universal Test and Treat (UTT) policy, most PLWH start ART early with high CD4 counts. Therefore, we investigated the association between baseline CD4 count with QoL and retention among PLWH during UTT in southwestern Uganda.<h4>Methods</h4>Between June 11, 2019, and June 10, 2020, we reviewed medical records for PLWH initiated on ART between April 2017 and September 2018 and interviewed them to collect QoL data. The primary exposure was CD4 count at ART initiation categorized as <500 cells/µl (low) versus ≥500 cells/µl (high). Physical and mental health-related QoL were the primary outcomes. Retention was the secondary outcome. Binary logistic regression was used to assess the association between the exposure and the primary outcome, while the Cox Proportional Hazard regression model was used for the secondary outcome.<h4>Results</h4>Of 300 participants, 59.7% initiated ART at a low baseline CD4 count. ART initiation at a higher baseline CD4 count, compared to a lower baseline CD4 count, was associated with a lower mental health-related QoL (adjusted odds ratio [aOR] 0.56, 95% confidence interval [CI] 0.32-0.97) but similar physical health-related QoL (aOR 0.54, 95% CI 0.10-2.78) and retention (adjusted hazard ratio [aHR] 0.30, 95% CI 0.08-1.14).<h4>Conclusion</h4>In this cohort of PLWH on ART, those who initiated the treatment at a higher baseline CD4 were less likely to have good mental health-related QoL functioning compared to those initiating at lower CD4 counts. However, the two groups were comparable in physical health-related QoL and retention in care. PLWH initiating ART at a higher baseline CD4 may require mental health-related support as part of treatment.https://doi.org/10.1371/journal.pone.0324024
spellingShingle Faith Tumuhairwe
Jonathan Izudi
Abel Munina
Anthanasio Bashaija
Francis Bajunirwe
Quality of life and retention in care among people living with HIV initiated on ART in the era of "Universal Test and Treat" policy at a large HIV Clinic in South Western Uganda.
PLoS ONE
title Quality of life and retention in care among people living with HIV initiated on ART in the era of "Universal Test and Treat" policy at a large HIV Clinic in South Western Uganda.
title_full Quality of life and retention in care among people living with HIV initiated on ART in the era of "Universal Test and Treat" policy at a large HIV Clinic in South Western Uganda.
title_fullStr Quality of life and retention in care among people living with HIV initiated on ART in the era of "Universal Test and Treat" policy at a large HIV Clinic in South Western Uganda.
title_full_unstemmed Quality of life and retention in care among people living with HIV initiated on ART in the era of "Universal Test and Treat" policy at a large HIV Clinic in South Western Uganda.
title_short Quality of life and retention in care among people living with HIV initiated on ART in the era of "Universal Test and Treat" policy at a large HIV Clinic in South Western Uganda.
title_sort quality of life and retention in care among people living with hiv initiated on art in the era of universal test and treat policy at a large hiv clinic in south western uganda
url https://doi.org/10.1371/journal.pone.0324024
work_keys_str_mv AT faithtumuhairwe qualityoflifeandretentionincareamongpeoplelivingwithhivinitiatedonartintheeraofuniversaltestandtreatpolicyatalargehivclinicinsouthwesternuganda
AT jonathanizudi qualityoflifeandretentionincareamongpeoplelivingwithhivinitiatedonartintheeraofuniversaltestandtreatpolicyatalargehivclinicinsouthwesternuganda
AT abelmunina qualityoflifeandretentionincareamongpeoplelivingwithhivinitiatedonartintheeraofuniversaltestandtreatpolicyatalargehivclinicinsouthwesternuganda
AT anthanasiobashaija qualityoflifeandretentionincareamongpeoplelivingwithhivinitiatedonartintheeraofuniversaltestandtreatpolicyatalargehivclinicinsouthwesternuganda
AT francisbajunirwe qualityoflifeandretentionincareamongpeoplelivingwithhivinitiatedonartintheeraofuniversaltestandtreatpolicyatalargehivclinicinsouthwesternuganda